Friday 6 November 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024.

Revenue: +29.2%
EPS: +178.4%
Free cash flow: +38.9%
Total debt: +1,765.6%

Quarter to September 2026, against a year earlier

253.57 12.11 +5.02%

Follow MRNA

Alert me

Market cap: $96.4B
P/E: 0.0×
Fwd P/E: −26.1×
Dividend yield: —
F-score: 3/9
Altman Z: 2.46
Beneish M: −3.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 6 Nov	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	4	1	1	3	+8 more TTM periods Free account
ROE Full definition →	(34.50%)	(39.00%)	(36.56%)	(28.87%)
ROA Full definition →	(21.79%)	(27.43%)	(26.41%)	(21.31%)
ROIC Full definition →	(109.92%)	(93.47%)	(76.00%)	(55.51%)
Return on Tangible Assets Full definition →	(37.94%)	(59.01%)	(58.49%)	(42.18%)
Average Days of Receivables Full definition →	197.61	2.79	11.65	34.55
Free Cash Flow per Share Full definition →	(5.10)	(3.13)	(4.06)	(5.33)
Free Cash Flow Full definition →	(2,044.00)	(1,244.00)	(1,603.00)	(2,075.00)
Capital Expenditures Full definition →	(259.00)	(171.00)	(137.00)	(202.00)
Other line items
Cash ROIC Full definition →	(17.02%)	(9.96%)	(12.13%)	(13.78%)
Accounts Receivable Turnover Full definition →	2.09	84.08	29.87	7.17
Accounts Payable Turnover Full definition →	6.91	9.98	8.96	2.40
Inventory Turnover Full definition →	5.64	6.57	12.65	6.43
Average Days of Payables Full definition →	52.00	35.71	33.91	133.30
Days of Inventory on Hand Full definition →	62.84	59.87	30.75	64.34
Tax Rate Full definition →	0.02	0.02	0.02	0.02
Research and Development Expense of Revenue Full definition →	105.27%	129.08%	131.46%	161.11%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	43.31%	44.00%	52.37%
Share Based Compensation of Revenue Full definition →	18.38%	20.74%	21.21%	24.85%
Operating CF/Net income Full definition →	0.64	0.34	0.46	0.66
Depreciation/Fixed assets Full definition →	0.10	0.09	0.08	0.07
Capex/Depreciation Full definition →	(1.23)	(0.90)	(0.78)	(1.36)
Revenue per Share Full definition →	6.30	5.60	5.63	5.00
Operating CF per Share Full definition →	(4.45)	(2.70)	(3.71)	(4.81)
Capex per Share Full definition →	(0.65)	(0.43)	(0.35)	(0.52)
Capex to Sales Full definition →	0.10	0.08	0.06	0.10

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly